BioSpace News Archive

Dahua Technology, a world-leading, video-centric provider of smart IoT solutions, has announced the launch of SafetyTemp (DHI-ASI7213X-T1), a thermal temperature monitoring station.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced new scientific findings have been highlighted today in a Science Translational Medicine cover publication.

Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by Karyopharm to be a specialty pharmacy partner for XPOVIO® (selinexor), a new oral treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least two lines of systemic therapy.

BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, reported financial results for the quarter ended March 31, 2020, and provided an operational update.

Full results from the positive Phase III ETHOS trial showed AstraZeneca’s triple-combination therapy PT010 (budesonide/glycopyrronium/formoterol fumarate) demonstrated a statistically significant reduction in the rate of moderate or severe exacerbations compared with two dual-combination therapies in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

Acceleron Pharma Inc. (NASDAQ:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today presented topline results of the PULSAR Phase 2 trial of sotatercept in patients with pulmonary arterial hypertension (PAH).

SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced positive testing results demonstrating the anti-viral properties of its silicon nitride which may be useful in the reduction of the spread of COVID-19.

The Association for the Accreditation of Human Research Protection Programs announced that it has awarded full accreditation to Western Michigan University Homer Stryker M.D. School of Medicine.

BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company” or “Bioasis”), today announced that it intends to satisfy its obligation to pay $26,177.21 in interest to the holders of its 7.5% unsecured debentures issued December 23, 2019

U.S. Secretary of Agriculture Sonny Perdue and FDA Commissioner Stephen M. Hahn, M.D., issued the following statement regarding food export restrictions pertaining to COVID-19